Notice :
Impact of Recent Change Health Care National Outage. Learn More
Notice :
Impact of Recent Change Health Care National Outage. Learn More

Clinical Trial

Trial Protocol ID XPORT-MF-044

Trial Description

A Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjects with JAK inhibitor (JAKi)-naïve myelofibrosis and moderate thrombocytopenia

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Mohit Narang, M.D.

Disease Types

Sponsor

  • Karyopharm Therapeutics Inc.

ClinicalTrials.gov NCT ID

  • NCT05980806